TC BioPharm Announces Additional Cost Reduction Steps to Improve Financial Standing and Streamline EfficienciesPRNewsWire • 01/03/24
TC BioPharm Announces Formation of Commercial Development Division, Led by Industry Veteran, Dr. Lauren Bor Ph.DPRNewsWire • 12/18/23
TC BioPharm Announces FDA Clearance of Phase 1B IND for TCB-008 in Acute Myeloid LeukemiaPRNewsWire • 11/27/23
TC BioPharm Announces Successful Completion of Safety Cohort and Positive DSMB ResultsPRNewsWire • 11/14/23
TC BioPharm Announces Streamlined Efficiencies and Reduces Overhead with Selection of Single Global CRO for Clinical TrialsPRNewsWire • 11/02/23
TC BioPharm Selects Excellos as CDMO in Anticipation of Expanded US Clinical Trial RequirementsPRNewsWire • 10/25/23
TC BioPharm Announces Submission of Investigational New Drug (IND) Application to U.S. FDA for Treatment of Relapse/Refractory AMLPRNewsWire • 10/23/23
TC BioPharm Announces Grant Funding in Collaboration with Queen Mary University of London (QMUL)PRNewsWire • 09/05/23
TC BioPharm to Present at H.C. Wainwright 25th Annual Global Investment ConferencePRNewsWire • 08/29/23